期刊文献+

NF-κB与MTA2在乳腺浸润性导管癌中的表达及相关性研究 被引量:1

Study of the expressions of NF-κB and MTA2 in infiltrating ductal carcinoma of breast and their correlation
下载PDF
导出
摘要 目的探讨核转录因子κB(NF-κB)与肿瘤转移相关基因2(MTA2)在乳腺浸润性导管癌组织中的表达及其相关性,并分析其与乳腺浸润性导管癌临床病理参数之间的关系。方法采用实时定量聚合酶链反应检测68例乳腺浸润性导管癌患者的癌组织及配对癌旁正常乳腺组织中NF-κB与MTA2基因的表达情况,并分析其与各临床参数的关系。结果 NF-κB和MTA2在乳腺浸润性导管癌组织中的表达都与年龄、肿瘤大小及组织学分期等指标无关(P>0.05);与淋巴结转移及TNM分期等指标有关(P<0.05)。此外,MTA2在乳腺浸润性导管癌ER阳性患者组织中呈高表达(P<0.05)。乳腺浸润性导管癌组织中NF-κB与MTA2的表达呈正相关(r=0.808,P=0.012)。结论检测NF-κB与MTA2在乳腺浸润性导管癌组织中的表达水平,可为乳腺浸润性导管癌的诊断,侵袭转移程度和预后提供理论依据。 Objective To investigate the expression of NF-κB and MTA2 in infiltrating ductal carcinoma of breast and their correlations to clinicopathologic character.Methods The expressions of and MTA2 in breast cancer and paired adjacent normal breast tissues of 68 breast invasive ductal cancer patients were detected by real-time quantitative PCR method,and their correlations to the clinicopathologic characteristics of breast invasive ductal cancer were analyzed.Results The expressions of NF-κB and MTA2 in breast invasive ductal carcinoma were not related to age,tumor size and histological stage(P〉0.05),and were positively correlated with lymph node metastasis and TNM stage(P〈0.05).In addition,MTA2 was highly expressed in the tissues of ER positive breast invasive ductal cancer patients(P〈0.05).There was a positive correlation between the expression of NF-κB and the expression of MTA2 in breast cancer tissue of the infiltrating ductal carcinoma of breast patients(r=0.808,P=0.012).Conclusion Measurement of NF-κB and MTA2 from breast invasive ductal carcinoma tissue may provide a theoretical basis for the diagnosis,progression and prognosis of infiltrating ductal carcinoma of breast.
出处 《国际检验医学杂志》 CAS 2018年第5期566-569,共4页 International Journal of Laboratory Medicine
关键词 乳腺浸润性导管癌 真核转录因子-κB 实时定量聚合酶链反应 infiltrating ductal carcinoma of breast nuclear factor-κB real-time quantitative PCR
  • 相关文献

参考文献1

二级参考文献51

  • 1Weinberg RA. The Biology of Cancer. New York: Garland Science, 2007.
  • 2Onder TT, Gupta PB, Mani SA, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008; 68:3645-3654.
  • 3Yang J,Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117:927-939.
  • 4Yang J, Mani SA, Weinberg RA. Exploring a new twist on tumor metastasis. Cancer Res 2006; 66:4549-4552.
  • 5Castanon I, Baylies MK. A Twist in fate: evolutionary comparison of Twist structure and function. Gene 2002; 287:11-22.
  • 6O'Rourke MP, Tam PP. Twist functions in mouse development. Int J Dev Bio12002; 46:401-413.
  • 7Mironchik Y, Winnard PT Jr, Vesuna F, et al. Twist overex-pression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Res 2005; 65:10801-10809.
  • 8Kwok WK, Ling MT, Lee TW, et al. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. CancerRes 2005; 65:5153-5162.
  • 9Vesuna F, van Diest P, Chen JH, Raman V. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun 2008; 367:235- 241.
  • 10Cheng GZ, Chan J, Wang Q, et aL Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 2007; 67:1979-1987.

共引文献51

同被引文献14

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部